腹腔镜/机器人辅助手术治疗Borrmann 4型胃癌的可行性:与常规开腹手术的比较研究
本研究纳入2008至2021年间接受腹腔镜/机器人辅助(MIS组,n=32)或开腹(Open组,n=68)根治性手术的100例Borrmann 4型胃癌患者,倾向性评分匹配后每组各30例分析。MIS组术后并发症(≥Clavien-Dindo III级)发生率为23.3%,Open组为13.3%,差异无统计学意义(P=0.50);MIS组3年总生存率优于Open组(80.2% vs 53.5%,log-rank P=0.03)。作者认为,若患者选择合适,微创手术可能发挥重要作用,但需更大样本进一步分析。
要点
- 匹配后MIS组与Open组各30例,术后严重并发症(≥Clavien-Dindo III级)发生率分别为23.3%和13.3%,差异无统计学意义(P=0.50)。
- MIS组3年总生存率优于Open组(80.2% vs 53.5%,log-rank P=0.03)。
- 多因素分析显示辅助化疗是总生存的独立有利预后因素(HR 0.33,95%CI 0.11-0.93);MIS为有利预后因素但未达统计学显著(HR 0.39,95%CI 0.39-1.07)。
核心结论
- 作者认为,鉴于该病预后差,多学科治疗是主要治疗手段,若选择合适患者,微创手术可能在治疗中发挥重要作用。
- 作者指出,需更大样本的进一步分析才能就肿瘤学疗效得出最终结论。
研究设计与样本
- 回顾性比较研究,纳入2008至2021年间接受根治性手术的100例Borrmann 4型胃癌患者,其中MIS组32例、Open组68例。
- 经倾向性评分匹配后,每组各提取30例进行分析,比较手术及中期生存结局。
主要发现
- 术后并发症(≥Clavien-Dindo III级)发生率MIS组为23.3%,Open组为13.3%,差异无统计学意义(P=0.50)。
- MIS组3年总生存率优于Open组(80.2% vs 53.5%,log-rank P=0.03)。
- 复发部位趋势相似。
- 多因素分析显示辅助化疗是总生存的独立有利预后因素(HR 0.33,95%CI 0.11-0.93)。
- MIS被提示为有利预后因素(HR 0.39,95%CI 0.39-1.07),但无统计学差异。
临床怎么用
- 原文结论指出,多学科治疗是主要治疗手段,若选择合适患者,微创手术可能发挥重要作用。
- 作者指出,需更大样本的进一步分析才能就肿瘤学疗效得出最终结论。
局限性
- 原文结论指出,需更大样本的进一步分析才能就肿瘤学疗效得出最终结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic surgery for early gastric cancer is regarded as a standard of care because of robust evidences obtained by several phase-III trials. Furthermore, the efficacy of laparoscopic radical surgery for advanced gastric cancer has been also reported. Meanwhile, the feasibility of laparoscopic surgery for Bormann type 4 gastric cancer, special type with unfavorable prognosis, remains unclear since excluded from eligibility of these trials. METHODS: This study included 100 patients with type 4 gastric cancer who underwent laparoscopic/robot-assisted (minimally invasive surgery (MIS) group; n = 32) or open (Open group; n = 68) curative surgery between 2008 and 2021. After propensity score matching, 30 patients in each group were extracted for analysis. Clinical data, including surgical and midterm survival outcomes, were retrospectively compared between the two groups. RESULTS: Incidences of postoperative complication (≥ Clavien-Dindo grade III) were recorded in 23.3% in the MIS group and 13.3% in the Open group, but no statistical significance was demonstrated (P = 0.50). The 3-year overall survival rate in the MIS group was better than that in the Open group (80.2% vs. 53.5%, log-rank, P = 0.03). The trend of recurrence site was similar. Multivariate analysis showed that adjuvant chemotherapy was an independent favorable prognostic factor (hazard ratio, 0.33, 95% confidence interval 0.11-0.93) for overall survival. MIS was indicated as a favorable prognostic factor (hazard ratio, 0.39, 95% confidence interval 0.39-1.07), but without statistical difference. CONCLUSION: While multidisciplinary treatment is mainstay of treatment because of the poor prognosis of this disease, minimally invasive surgery may play an important role in treatment if appropriate patient selection is done. Further analyses with larger sample size are necessary to reach a final conclusion regarding oncological efficacy.
引用
- Akimoto E, Kinoshita T, Yura M, et al. Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery. Surg Endosc. 2024. PMID: 38691134. doi:10.1007/s00464-024-10857-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。